“The Cell Game” by Alex Prud’homme examines Sam Waksal’s risky ventures in the biotech world. It details his role in ImClone’s cancer drug development and the ensuing scandal. Waksal’s pursuit of quick profits highlights the tensions between innovation and ethics in the industry, ultimately revealing significant consequences for patients and investors.